Shore, Neal D <br/><br/>
Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study.  [electronic resource] 

 -  The Lancet. Oncology  Feb 2016 
 - 153-163 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-5488 
<br/><br/><label>Standard No.: </label>10.1016/S1470-2045(15)00518-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Anemia--chemically induced<br/>Anilides--adverse effects<br/>Arthralgia--chemically induced<br/>Back Pain--chemically induced<br/>Benzamides<br/>Constipation--chemically induced<br/>Disease Progression<br/>Disease-Free Survival<br/>Double-Blind Method<br/>Dyspnea--chemically induced<br/>Fatigue--chemically induced<br/>Fractures, Spontaneous--chemically induced<br/>Heart Failure--chemically induced<br/>Hot Flashes--chemically induced<br/>Humans<br/>Hydronephrosis--chemically induced<br/>Hypertension--chemically induced<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--chemically induced<br/>Nausea--chemically induced<br/>Nitriles--adverse effects<br/>Patient Dropouts<br/>Phenylthiohydantoin--adverse effects<br/>Prostatic Neoplasms, Castration-Resistant--drug therapy<br/>Tosyl Compounds--adverse effects